Managing Immunotherapy Side Effects in Cancer Patients

This CE course for Registered Nurses (RNs) explores the critical role of immunotherapy in modern cancer treatment, focusing on managing its associated side effects, known as immune-related adverse events (irAEs). Immunotherapies such as checkpoint inhibitors and CAR T-cell therapy represent breakthroughs in oncology but come with unique challenges. These therapies stimulate the immune system to target cancer cells, which can also lead to unintended inflammation in healthy tissues. The course provides nurses with an in-depth understanding of the mechanisms behind immunotherapy and equips them with the tools to identify and manage irAEs across organ systems.

Participants will learn to recognize symptoms like colitis, pneumonitis, endocrinopathies, and dermatologic reactions early, ensuring prompt intervention. The course emphasizes evidence-based supportive care, proper documentation, safe handling of immunotherapies, and understanding drug interactions. Nurses will also gain skills to educate patients and families on self-monitoring and responding to symptoms. Special attention is given to addressing the needs of diverse populations, including older adults, immunocompromised patients, and those in palliative care settings.

This comprehensive course strengthens interdisciplinary collaboration, enhances clinical decision-making, and ensures safe, patient-centered care for individuals undergoing immunotherapy.

Educational Objectives

• Explain the mechanisms and types of cancer immunotherapies and their role in treatment.
• Identify and assess common and rare immune-related adverse events (irAEs) for early detection.
• Educate patients and families on side effect monitoring, self-care, and when to seek medical attention.
• Demonstrate the use of immunotherapy in cancer treatment, including managing side effects, drug interactions, and specific considerations for different patient populations.
• Develop strategies for safely handling, administering, and managing chemotherapy side effects, ensuring patient safety and effective supportive care.

Who Should Do This Course

This course is ideal for:

• Registered Nurses (RNs)
• Nurse Practitioners (NPs)

Especially those working in:

• Oncology
• Critical Care
• Hospice and Palliative Care
• Medical-Surgical Units
• Infusion Centers
• Community and Outpatient Settings

This course is particularly valuable for nurses involved in the direct care of patients receiving immunotherapies and those who educate families on symptom management and side effect monitoring.

Did You Know?

• Immune checkpoint inhibitors have increased survival rates in advanced melanoma by over 30%. (NEJM, 2015)
• Early recognition and treatment of irAEs can reduce hospitalization rates by 50%. (JCO Oncology Practice, 2018)
• Up to 20% of patients treated with immunotherapy develop endocrine complications like hypothyroidism. (Cancer Immunol Res, 2019)
• Nurses are often the first to identify irAEs, which is critical for patient safety. (Oncology Nursing Society, 2021)
• Use of structured toxicity checklists can improve early detection of irAEs by 40%. (BMJ Support Palliat Care, 2020)